Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moria Smoski

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Behaviour Research and Therapy|May 6, 2023
Parsing within & between-person dynamics of therapy homework completion and clinical symptoms in two cognitive behavioral treatments for adults with anhedoniaPaul M Cernasov, Jessica L Kinard, Erin Walsh, et al.
Nature Reviews. Drug Discovery|December 29, 2018
The first implementation of the NIMH FAST-FAIL approach to psychiatric drug developmentAndrew D Krystal, Diego A Pizzagalli, Sanjay J Mathew, et al.
Journal of Affective Disorders|June 14, 2021
Multilevel growth curve analyses of behavioral activation for anhedonia (BATA) and mindfulness-based cognitive therapy effects on anhedonia and resting-state functional connectivity: Interim results of a randomized trial<sup>✰</sup>Paul Cernasov, Erin C Walsh, Jessica L Kinard, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 17, 2020
Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)Diego A Pizzagalli, Moria Smoski, Yuen-Siang Ang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 14, 2021
Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)Diego A Pizzagalli, Moria Smoski, Yuen-Siang Ang, et al.
Journal of Affective Disorders|July 19, 2023
Using latent profile analyses to classify subjects with anhedonia based on reward-related measures obtained in the FAST-MAS studySabrina M Darrow, Diego A Pizzagalli, Moria Smoski, et al.
Nature Medicine|April 2, 2020
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedoniaAndrew D Krystal, Diego A Pizzagalli, Moria Smoski, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Behaviour Research and Therapy|May 6, 2023
Parsing within & between-person dynamics of therapy homework completion and clinical symptoms in two cognitive behavioral treatments for adults with anhedoniaPaul M Cernasov, Jessica L Kinard, Erin Walsh, et al.
Nature Reviews. Drug Discovery|December 29, 2018
The first implementation of the NIMH FAST-FAIL approach to psychiatric drug developmentAndrew D Krystal, Diego A Pizzagalli, Sanjay J Mathew, et al.
Journal of Affective Disorders|June 14, 2021
Multilevel growth curve analyses of behavioral activation for anhedonia (BATA) and mindfulness-based cognitive therapy effects on anhedonia and resting-state functional connectivity: Interim results of a randomized trial<sup>✰</sup>Paul Cernasov, Erin C Walsh, Jessica L Kinard, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 17, 2020
Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)Diego A Pizzagalli, Moria Smoski, Yuen-Siang Ang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 14, 2021
Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)Diego A Pizzagalli, Moria Smoski, Yuen-Siang Ang, et al.
Journal of Affective Disorders|July 19, 2023
Using latent profile analyses to classify subjects with anhedonia based on reward-related measures obtained in the FAST-MAS studySabrina M Darrow, Diego A Pizzagalli, Moria Smoski, et al.
Nature Medicine|April 2, 2020
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedoniaAndrew D Krystal, Diego A Pizzagalli, Moria Smoski, et al.
Pageof 2